Critical Trio Exome Benefits In-Time Decision-Making for Pediatric Patients With Severe Illnesses

En-Ting Wu1, Wuh-Liang Hwu1,2, Yin-Hsiu Chien1,2

  • 1Department of Paediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.

Insights

Whole-exome sequencing rapidly diagnosed genetic conditions in critically ill children, improving timely management and resource use in pediatric intensive care units (PICUs). This cost-effective approach aids rare disease diagnosis for severe pediatric illnesses.

Area of Science:

  • Medical Genetics
  • Pediatric Critical Care

Background:

  • Undiagnosed genetic conditions pose significant challenges in pediatric intensive care units (PICUs).
  • Whole-exome sequencing (WES) is a powerful diagnostic tool but often faces limitations in cost and turnaround time for critical cases.

Purpose of the Study:

  • To assess the feasibility and efficacy of a rapid, cost-effective whole-exome sequencing (WES) approach for diagnosing rare genetic diseases in critically ill pediatric patients.
  • To improve diagnostic yield and inform clinical management in a timely manner within the PICU setting.

Main Methods:

  • Utilized a fast, standard whole-exome sequencing (WES) platform combined with text mining for variant prioritization.
  • Analyzed data from critically ill pediatric patients suspected of genetic disorders over a 1-year period in a tertiary referral hospital.

Main Results:

  • Achieved a molecular diagnosis for 52.5% of patients (21/40) within an average of 6.2 working days.
  • Identified previously unreported mutations in Taiwan, leading to altered clinical management for 81% of diagnosed patients.
  • Recommended specific treatments, including medications and transplantation, for a significant portion of diagnosed individuals.

Conclusions:

  • The implemented WES algorithm offers a balanced approach to cost and speed for uncovering genetic conditions in critically ill infants and children.
  • This rapid diagnostic capability in PICUs facilitates timely patient management and optimizes resource utilization.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
269
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
198
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
260
Classification of Illness01:17

Classification of Illness

The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
8.6K
Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
5.2K